Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 32,415	$ 19,461	$ 63,329	$ 38,334
General and administrative	9,278	8,327	18,416	16,316
Total operating expenses	41,693	27,788	81,745	54,650
Loss from operations	(41,693)	(27,788)	(81,745)	(54,650)
Other income, net:
Interest income	2,966	2,565	5,266	5,216
Interest expense	(60)	(88)	(128)	(183)
Change in fair value of derivative liabilities	(900)		(2,550)
Other income, net	207	239	395	242
Total other income, net	2,213	2,716	2,983	5,275
Net loss	$ (39,480)	$ (25,072)	$ (78,762)	$ (49,375)
Net loss per share, basic	$ (0.42)	$ (0.61)	$ (0.98)	$ (1.25)
Net loss per share, diluted	$ (0.42)	$ (0.61)	$ (0.98)	$ (1.25)
Weighted average shares of common stock outstanding used to compute basic net loss per share	94,140,286	40,934,361	80,317,588	39,544,867
Weighted average shares of common stock outstanding, used to compute diluted net loss per share	94,140,286	40,934,361	80,317,588	39,544,867

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.